Combining the mTOR Inhibitor Everolimus and Gemcitabine in Relapsed/Refractory Peripheral T-Cell Lymphomas

Huang, L; Jiang, XM; Li, WY; Guo, HG; Wei, XJ; Liu, SC; Chen, FL; Liang, ZL

BLOOD, 2020; 136 ():